Mission: Our mission is to build a global, patient-forward, cancer learning network where peer and professional navigators guide patients through the innovations of today’s molecular medicine.
View our program brochure here
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Darzalex Regimen May Improve MRD Responses in Multiple Myeloma
How to Self Advocate When Insurance Says No to Cancer Treatment Coverage
FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset